Abstract: An assay cartridge for sensing multiple analytes includes a capture platform and main body. The capture platform includes appendages. The main body includes first, second, and third assemblies of reaction compartments as well as first and second wash basins. The main body includes a capture platform cradle that supports the capture platform. Each appendage is coupled to a capture agent that specifically binds to an analyte. The first reaction compartments each comprise a matrix that includes the analyte. The first wash basin includes a first wash solution that removes non-specific binding between the analyte and capture agent. The second reaction compartments each include a detection antibody. The second wash basin includes a second wash solution that remove non-specific binding of the detection antibody to the analyte. The third reaction compartments each include a substrate that reacts with a conjugated enzyme of the detection antibody and changes color as a result.

Abstract: An assembly that includes a first device. The first device includes a main body and a ring disposed around the main body. The main body is provided with at least one protuberance and at least one recess, the at least one protuberance being complementary in number with the at least one recess. The first device is adapted to fit to an adjacent second device by virtue of engagement of the at least one protuberance or the at least one recess to the adjacent second device.

Abstract: N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, pharmaceutically acceptable salts thereof, and/or mixtures thereof, as well as, pharmaceutical compositions thereof, methods of treatment therewith, and processes of making N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide and intermediates thereof.

Abstract: N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, pharmaceutically acceptable salts thereof, and/or mixtures thereof, as well as, pharmaceutical compositions thereof, methods of treatment therewith, and processes of making N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide and intermediates thereof.

Abstract: N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, pharmaceutically acceptable salts thereof, and/or mixtures thereof, as well as, pharmaceutical compositions thereof, methods of treatment therewith, and processes of making N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide and intermediates thereof.